Efficacy and safety of ATA129, partially matched allogeneic third-party Epstein-Barr virus-targeted cytotoxic T lymphocytes in a multicenter study for post-transplant lymphoproliferative disorder Meeting Abstract

  

Authors:	Prockop, S.; Li, A.; Baiocchi, R. A.; Bunin, N.; Mahadeo, K. M.; Nemecek, E. R.; Nikiforow, S.; Reshef, R.; Tsai, D. E.; Navarro, W. H.; O'Reilly, R. J.
Abstract Title:	Efficacy and safety of ATA129, partially matched allogeneic third-party Epstein-Barr virus-targeted cytotoxic T lymphocytes in a multicenter study for post-transplant lymphoproliferative disorder
Meeting Title:	59th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	130
Issue:	Suppl. 1
Meeting Dates:	2017 Dec 9-12
Meeting Location:	Atlanta, GA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2017-12-07
Language:	English
ACCESSION:	WOS:000432419704112
PROVIDER:	wos
DOI:	10.1182/blood.V130.Suppl_1.4520.4520
Notes:	Meeting Abstract: 4520 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/127129